Literature DB >> 28222495

Reversible thrombotic mitral valve stenosis after transcatheter mitral valve replacement (TMVR): Is life-long anticoagulation therapy necessary?

Vladan Hudec1, Martin Bena1, Panagiotis Artemiou1, Ivo Gasparovic1, Michal Hulman1.   

Abstract

We describe a case of reversible thrombotic mitral valve stenosis following a valve-in-ring transcatheter mitral valve replacement. Life-long oral anticoagulation in patients who underwent transcatheter mitral valve replacement might be beneficial.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  bioprosthetic valve thrombosis; transcatheter mitral valve replacement

Mesh：

Substances：

Year:  2017        PMID： 28222495     DOI： 10.1111/jocs.13109

Source DB:  PubMed          Journal:  J Card Surg        ISSN： 0886-0440            Impact factor:   1.620


  3 in total

1.  Transcatheter mitral valve replacement: an evolution of a revolution.

Authors:  Mohamad Alkhouli; Fahad Alqahtani; Sami Aljohani
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

2.  Transcatheter mitral valve replacement: still a long way to go!

Authors:  Thierry Carrel
Journal:  Ann Transl Med       Date:  2017-09

Review 3.  Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: A systematic review and meta-analysis.

Authors:  Junjie Hu; Yan Chen; Sijin Cheng; San Zhang; Kaiqin Wu; Wenli Wang; Yongxin Zhou
Journal:  J Card Surg       Date:  2018-07-10       Impact factor: 1.620
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.